Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2000

View Archived Issues

Eurand expands drug delivery capabilities

NIAID signs agreement with MVI/PATH for malaria vaccine research

Pig small intestine submucosa shows efficacy in wound healing

Aquila receives milestone payments under licensing agreements

NK1 receptor antagonist CP-99994 tested in ferret model of emesis

Oxford BioMedica to collaborate with AstraZeneca in drug discovery

Phase III results positive for memantine in AD

New Videx capsule formulation approved in France

Nastech's intranasal apomorphine compared to Viagra in phase II pilot trial

Magainin to begin clinical program for squalamine in genetic bone disorder

Buccal insulin/metformin combination therapy tested in type II diabetes

SciClone awarded grant to study novel immunomodulator in TB

Combidex NDA accepted for FDA review

PathoGenesis announces approval, distribution agreement for TOBI

Abbott launches new sedative for ICU use only

Use of FK-506 as topical analgesic disclosed

Cytotoxic artemisinin derivatives designed at Hong Kong U. of Science & Technology

U. of Texas designs new DNA-cleaving compounds

Antianginal agents with minimal arrhythmogenic potential developed at Lafon

Small-molecule transthyretin amyloid fibril inhibitors emerge from structure-based design program

Kinetix enters research collaboration with Dana-Farber Cancer Institute

Beijing-based researchers discover new antitumor indole derivatives

Allergan and Dura enter commercialization agreement for multiple products

Antiplatelet agents under study at Chinese centers

BIBN-4096BS: an extremely potent and selective CGRP antagonist for migraine

Second orphan drug designation granted for Maxamine

Selective 5-HT1D agonist L-775606 has reduced coronary vasoconstrictor effects vs. sumatriptan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...